Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series

Goncalves, I; Burbury, K; Michael, M; Iravani, A; Ravi Kumar, AS; Akhurst, T; Tiong, IS; Blombery, P; Hofman, MS; Westerman, D; Hicks, RJ; Kong, G

Goncalves, I (reprint author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic 3000, Australia.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019; 46 (9): 1902

Abstract

PurposePeptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) is an effective therapy for metastatic neuroendocrine neoplasia (NEN), but......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索